Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeadlam Regulatory News (HEAD)

Share Price Information for Headlam (HEAD)

Share Price is delayed by 15 minutes
Get Live Data
28.40    -1.00 (-3.40%)
Bid:
28.10
Ask:
28.30
Spread: 0.20 (0.712%)
Market Cap: £22.80m
HEAD Live PriceLast checked at - London Stock Exchange

Intraday Headlam Share Chart

Performance Share Plan awards

11 Apr 2019 08:00

RNS Number : 8761V
Headlam Group PLC
11 April 2019
 

11 April 2019

Headlam Group plc

(the 'Company')

 

Grant of awards under the Company's Performance Share Plan ('PSP')

On 10 April 2019, the Company granted awards in the form of nil-cost options over a total of 304,260 ordinary shares of 5 pence each in the Company ('Ordinary Shares') under the Company's PSP, including to the following Executive Directors:

Executive Director

Number of Ordinary Shares over which award granted

Steve Wilson (Chief Executive)

 86,459

Chris Payne (Chief Financial Officer)

63,707

The number of Ordinary Shares over which the awards were granted was calculated based on a share price of 448.3 pence per Ordinary Share, being the average mid-market closing share price for the five business days prior to the grant date, as derived from the London Stock Exchange Daily Official List.

The awards have been granted subject to performance conditions based on: (1) the Company's compound annual growth in Earnings Per Share ('EPS') over a three-year performance period starting with 2019 (as regards 80% of the Ordinary Shares subject to the award); and (2) the Company's Total Shareholder Return ('TSR') over that performance period relative to the TSRs of the constituents of the FTSE SmallCap Index (excluding investment trusts) (as regards 20% of the Ordinary Shares subject to the award). The awards are subject to a further underpin performance condition that the extent of vesting reflects the overall financial performance of the Company over the three-year performance period.

The awards, which are subject to the Malus and Clawback conditions of the PSP, will ordinarily vest on the date on which the Company's Remuneration Committee determines the extent to which the performance conditions have been satisfied (the 'Vesting Date').

The awards to the Executive Directors are further subject to an additional two-year holding period from the Vesting Date. During the holding period these shares will accrue a dividend equivalent in the form of shares, calculated on a re-investment basis.

Enquiries:

 

Headlam Group plc

Tel: 01675 433 000

Steve Wilson, Chief Executive

Chris Payne, Chief Financial Officer

Catherine Miles, Director of Communications

 Email: headlamgroup@headlam.com

Investec Bank plc (Corporate Broker)

Tel: 020 7597 5970

David Flin / Alex Wright

Panmure Gordon (UK) Limited (Corporate Broker)

Tel: 020 7886 2500

Erik Anderson / Dominic Morley / Ailsa MacMaster

Buchanan (Financial PR and IR)

Tel: 020 7466 5000

Mark Court / Sophie Wills / Catriona Flint

 

 

Notification and public disclosure of transactions by PDMRs and persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Steve Wilson

2.

Reason for the notification

 

 

a)

Position / status

Chief Executive

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Headlam Group plc

 

b)

LEI

213800I4AZZUJEYX9O90

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each.

b)

Identification code

ISIN: GB0004170089

c)

Nature of the transaction

Grant of nil-cost options over Ordinary Shares under the Company's Performance Share Plan

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

N/A

86,459

e)

Aggregated information

- Volume

- Price

N/A

f)

Date of the transaction

10 April 2019

g)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Chris Payne

2.

Reason for the notification

 

 

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Headlam Group plc

 

b)

LEI

213800I4AZZUJEYX9O90

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each.

b)

Identification code

ISIN: GB0004170089

c)

Nature of the transaction

Grant of nil-cost options over Ordinary Shares under the Company's Performance Share Plan

d)

Price(s) and

volume(s)

Price(s)

Volume(s)

N/A

63,707

e)

Aggregated information

- Volume

- Price

N/A

f)

Date of the transaction

10 April 2019

g)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHMMGMDVMMGLZG
Date   Source Headline
24th Nov 20207:00 amRNSNotice of cyber security incident
19th Nov 20207:00 amRNSTrading Update
5th Nov 20207:00 amRNSCOVID-19 Operational Update
8th Oct 20201:36 pmRNSDirector/PDMR Shareholding
5th Oct 20202:29 pmRNSEmployee SAYE scheme & Director/PDMR shareholding
14th Sep 20203:43 pmRNSGrant of Awards under Long-Term Incentive Plans
10th Sep 20208:30 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSInterim Results
13th Aug 20208:44 amRNSHolding(s) in Company
10th Aug 202012:05 pmRNSHolding(s) in Company
7th Aug 20204:35 pmRNSPrice Monitoring Extension
7th Aug 20207:00 amRNSHolding(s) in Company
28th Jul 202011:13 amRNSDirector/PDMR Shareholding
28th Jul 20209:18 amRNSHolding(s) in Company
27th Jul 20207:00 amRNSTrading Update and New Distribution Centre
23rd Jun 20208:50 amRNSHolding(s) in Company
22nd May 202011:21 amRNSResult of AGM
22nd May 20207:00 amRNSAGM Trading Update
14th May 202012:08 pmRNSSecond Price Monitoring Extn
14th May 202012:02 pmRNSPrice Monitoring Extension
29th Apr 202010:34 amRNSDisclosure of Rights Attached to Equity Shares
28th Apr 202012:08 pmRNSSecond Price Monitoring Extn
28th Apr 202012:02 pmRNSPrice Monitoring Extension
27th Apr 20202:35 pmRNSDirector Declaration
27th Apr 202012:08 pmRNSSecond Price Monitoring Extn
27th Apr 202012:02 pmRNSPrice Monitoring Extension
23rd Apr 20202:20 pmRNSHolding(s) in Company
7th Apr 20207:00 amRNSNotification of Major Holdings
2nd Apr 20203:40 pmRNSAnnual Report and Accounts and Notice of AGM
31st Mar 20208:34 amRNSTotal Voting Rights
25th Mar 20208:00 amRNSCOVID-19 Trading Update
11th Mar 20204:41 pmRNSSecond Price Monitoring Extn
11th Mar 20204:35 pmRNSPrice Monitoring Extension
5th Mar 20207:00 amRNSFinal Results
3rd Mar 202012:37 pmRNSOption Exercise and Transfer of Treasury Shares
26th Feb 202011:08 amRNSHolding(s) in Company
11th Feb 20207:00 amRNSNotification of Final Results
31st Jan 202010:00 amRNSTotal Voting Rights
24th Jan 20204:40 pmRNSSecond Price Monitoring Extn
24th Jan 20204:35 pmRNSPrice Monitoring Extension
16th Jan 20207:00 amRNSPre-Close Trading Update
7th Jan 20202:46 pmRNSOption Exercise and Transfer of Treasury Shares
31st Dec 20191:19 pmRNSTotal Voting Rights
23rd Dec 20194:31 pmRNSOption Exercise and Transfer of Treasury Shares
19th Dec 201911:27 amRNSHolding(s) in Company
10th Dec 20191:34 pmRNSOption Exercise and Transfer of Treasury Shares
3rd Dec 20193:22 pmRNSAdditional Listing and TVR
29th Nov 20197:00 amRNSTotal Voting Rights
26th Nov 201910:47 amRNSOption Exercise and Transfer of Treasury Shares
25th Nov 20198:30 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.